Archive · 17 Dec 2025
Government Acknowledges Gender Bias in Medical Research
The government has admitted that there is a problem with gender bias in medical research.
This means that sometimes, studies and trials do not consider the differences between men and women, which can affect how diseases are treated.
For example, heart disease, autoimmune disorders, and chronic pain can manifest differently in women.
The government says that scientific guidelines require avoiding such bias to ensure fair and effective medical research.
This information was shared in response to a question in the Rajya Sabha, the upper house of India's Parliament.
The Union government acknowledged global gender bias in medical research and clinical trials.
Differences in disease manifestation and treatment outcomes among women were highlighted, particularly in heart disease, autoimmune disorders, and chronic pain.
Sex- and gender-related considerations in biomedical research are recognized in scientific literature.
Ethical frameworks require avoiding exclusion or unfair bias based on sex or gender.
The information was provided in a written reply to an unstarred question in the Rajya Sabha by Minister of State for Health and Family Welfare Prataprao Jadhav.
- Who
- Union government, Minister of State for Health and Family Welfare Prataprao Jadhav
- What
- Acknowledgment of gender bias in medical research and clinical trials
- When
- Tuesday (specific date not mentioned)
- Where
- Rajya Sabha
- Why
- To address global observations of gender bias in medical research and its impact on treatment outcomes
- Acknowledgment
- Gender bias in medical research and clinical trials
- Areas of Concern
- Heart disease, autoimmune disorders, chronic pain
- Ethical Frameworks
- Require avoidance of exclusion or unfair bias based on sex or gender
- Response Context
- Written reply to an unstarred question in the Rajya Sabha
- Minister
- Prataprao Jadhav, Minister of State for Health and Family Welfare
